Synthesis of novel perillyl–dihydropyrimidinone hybrids designed for antiproliferative activity

MedChemComm
2018.0

Abstract

A series of fifteen novel dihydropyrimidinone hybrid compounds were synthesized in good yields <i>via</i> a multicomponent reaction combined with the Huisgen reaction. The antiproliferative activity was investigated against nine tumor cell lines, and four hybrid compounds (TGI < 10 μM) showed promising antiproliferative activity against the tumor cell lines OVCAR-3 (ovarian), UACC-62 (melanoma) and U251 (glioma). Several hybrid compounds assayed have high TGI values (TGI 147.92-507.82) for the human keratinocyte cell line (HaCat), which reveals selectivity to cancer cells.

Knowledge Graph

Similar Paper

Synthesis of novel perillyl–dihydropyrimidinone hybrids designed for antiproliferative activity
MedChemComm 2018.0
Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity
European Journal of Medicinal Chemistry 2013.0
Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents
European Journal of Medicinal Chemistry 2014.0
Synthesis and biological evaluation of novel pyrimidine–benzimidazol hybrids as potential anticancer agents
Bioorganic &amp; Medicinal Chemistry Letters 2014.0
Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety
European Journal of Medicinal Chemistry 2018.0
Synthesis and anticancer activity of new dihydropyrimidinone derivatives
European Journal of Medicinal Chemistry 2018.0
Design and synthesis of novel 1,2,3-triazole–pyrimidine–urea hybrids as potential anticancer agents
Bioorganic &amp; Medicinal Chemistry Letters 2015.0
One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties
European Journal of Medicinal Chemistry 2014.0
Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity
Bioorganic &amp; Medicinal Chemistry Letters 2013.0
Design, synthesis and preliminary biological evaluation of new [1,2,3]triazolo[4,5- d ]pyrimidine/thiourea hybrids as antiproliferative agents
European Journal of Medicinal Chemistry 2017.0